|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Institute of Physiology and Center for Human Integrative Physiology, University of Zurich, Zurich, Switzerland; and 2School of Medicine, Second University of Naples, Naples, Italy
Submitted 14 August 2008 ; accepted in final form 23 October 2008
| ABSTRACT |
|---|
|
|
|---|
transporter; collecting duct
The Cl–/anion exchanger pendrin (SLC26A4) belongs to a large superfamily of anion transporters and is predominantly expressed in the inner ear, thyroid gland, and kidney (8, 16). Mutations in pendrin cause Pendred syndrome, which is associated with sensorineural deafness and goiter (Online Mendelian Inheritance in Man Database No. 274600 [OMIM] ) (7). In the kidney, pendrin expression is restricted to the apical side of non-type A intercalated cells (i.e., type B and non-type A/B intercalated cells) in the connecting segment and cortical collecting duct (13, 20, 29). There, pendrin has been implicated in bicarbonate secretion into urine stimulated during metabolic alkalosis (20). Indeed, pendrin can function as a Cl–/HCO3– exchanger, as evident from experiments in cells with exogenous expression of pendrin (21). Moreover, pendrin-deficient mice secrete less bicarbonate in isolated perfused cortical collecting ducts during metabolic alkalosis (20). Also consistent with a role in the regulated secretion of bicarbonate during metabolic alkalosis, we and several other groups have observed that pendrin abundance was reduced during metabolic acidosis induced by oral NH4Cl loading (9, 18, 27). These findings were interpreted as the downregulation of pendrin due to metabolic acidosis.
More recently, Quentin et al. (19), Vallet et al. (24), Verlander et al. (26), and Wall et al. (30) have described that pendrin expression was regulated by urinary Cl– excretion and suggested a role in transcellular Cl– absorption. In particular, they noted that maneuvers increasing urinary Cl– excretion decreased pendrin expression. Treatments inducing Cl– depletion and stimulating renal Cl– reabsorption were associated with higher pendrin protein levels (19, 24, 26, 30).
These data raised the question of whether the downregulation in pendrin abundance observed in NH4Cl-loaded animals was solely due to Cl– loading or was also, at least in part, due to the metabolic acidosis induced by NH4+ loading. To this end, in the present study, we examined the correlation between pendrin expression and urinary acid and Cl– excretion by Western blot analysis in several animal models. Systemic acid-base homeostasis and urinary acid excretion were manipulated by providing mice with different diets, including NH4Cl, (NH4)2SO4, the carbonic anhydrase inhibitor acetazolamide, and high protein (50%). All these treatments have been shown to induce metabolic acidosis or to provide an acid challenge leading to increased urinary acid excretion [i.e., high urinary ammonium and net acid excretion (NAE)] (6, 12, 22, 31). In addition, other groups of animals received either only sucrose (which was added to all diets), a diet containing a normal protein content (20%), or NaCl and Na2SO4 to provide a Cl– load, or a control for (NH4)2SO4 loading, respectively. The results indicate that pendrin expression is regulated by urinary Cl– excretion, but the abundance may also be reduced during metabolic acidosis despite low urinary Cl– excretion.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies against pendrin.
The antibodies against mouse pendrin were raised in the rabbit and guinea pig against the COOH-terminal sequence CKDPLDLMEAEMNAEELDVQDEAMRRLAS coupled to KLH (Pineda Antibody Service, Berlin, Germany). This sequence has been used previously to raise antibodies against pendrin (14). The guinea pig and rabbit antisera recognized only one major band of
120 kDa, and the band was abolished by preincubation of serum with the immunizing peptide and absent in preimmune serum (see Supplemental Fig. 1).1 Both sera were also tested by immunohistochemistry and stained the luminal side of intercalated cells only in the late distal tubule, connecting segment, and cortical collecting duct, as previously described for other anti-pendrin antibodies (14, 20, 27, 29). No staining was observed when the preimmune serum was used or when the immune serum was preincubated with the immunizing peptide (see Supplemental Fig. 2). We used the guinea pig serum for immunoblot analysis and the rabbit serum for immunohistochemistry.
Western blot analysis. Mice were killed, and kidneys rapidly harvested and transferred into ice-cold K-HEPES buffer (200 mM mannitol, 80 mM K-HEPES, and 41 mM KOH; pH 7.5) with pepstatin, leupeptin, K-EDTA, and PMSF added as protease inhibitors. Samples were homogenized with a tip sonicator and centrifuged at 1,000 g for 10 min at 4°C, and the supernatant was saved. Subsequently, the supernatant was centrifuged at 100,000 g for 1 h at 4°C, and the resultant pellet was resuspended in K-HEPES buffer containing protease inhibitors. After measurement of the total protein concentration (Bio-Rad protein kit), 75 µg of membrane protein were solubilized in Laemmli sample buffer, and SDS-PAGE was performed on 10% polyacrylamide gels. For immunoblot analysis, proteins were transferred electrophoretically from unstained gels to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Bedford, MA). After being blocked with 5% milk powder in Tris-buffered saline and 0.1% Tween 20 for 60 min, blots were incubated with guinea pig anti-pendrin immune serum and mouse monoclonal anti-actin (42 kDa, Sigma) at 1:500 dilution for either 2 h at room temperature or overnight at 4°C. After being washed and subsequent blocked, blots were incubated with secondary antibodies conjugated with alkaline phosphatase or horseradish peroxidase [goat anti-rabbit: 1: 5,000, goat anti-guinea pig: 1:5,000, and donkey anti-mouse: 1:10,000 (Promega)] for 1 h at room temperature. Antibody binding was detected with an enhanced chemiluminescence kit (Pierce) in the case of horseradish peroxidase-linked antibodies and with the CDP Star kit (Roche) for alkaline phosphatase-linked antibodies before the detection of chemiluminescence with the Diana III Chemiluminescence detection system. Bands were quantified with Aida Image Analyzer software (Raytest).
Immunohistochemistry. Mice were anesthetized with ketamine-xylazine and perfused through the left ventricle with PBS followed by paraformaldehyde-lysine-periodate fixative (PLP) (15). Kidneys were removed and fixed overnight at 4°C by an immersion in PLP. Kidneys were washed three times with PBS and rapidly frozen with liquid propane, and 5-µm cryosections were cut after cryoprotection with 2.3 M sucrose in PBS.
Indirect immunohistochemistry was carried out as previously described (4, 27). Sections were incubated with 1% SDS for 5 min, washed three times with PBS, and incubated with PBS containing 1% BSA for 15 min before the primary antibodies. The primary antibodies [rabbit and guinea pig anti-pendrin, mouse monoclonal anti-calbindin D28k (SWANT, Bellinzona, Switzerland), and goat anti-aquaporin 2 (AQP2; Chemicon, now Millipore)] were diluted in PBS at 1:1,000, 1: 20,000, and 1:400, respectively, and applied for either 75 min at room temperature or overnight at 4°C. Sections were then washed twice for 5 min with high-NaCl PBS (PBS + 2.7% NaCl) and once with PBS and incubated with dilutions of the secondary antibodies [donkey anti-rabbit Alexa 594, donkey-anti guinea-pig Cy3, donkey anti-mouse Alexa 488, and donkey anti-goat 488 (Molecular Probes)] at 1:1,000; 1:400, 1:400, and 1:400, respectively, combined with 4',6-diamidino-2-phenylindole to counterstain cell nuclei (1:200) for 1 h at room temperature. Sections were again washed twice with high-NaCl PBS and once with PBS before being mounted with VectaMount (Vector Laboratories, Burlingame, CA). Sections were viewed with a confocal microscope (Leica CLSM). Images were processed (overlays) using Adobe Photoshop. Cells were counted as previously described (27) in at least three sections from four animals each for each treatment group. Omission of primary antibodies or preincubation of anti-pendrin sera with the immunizing peptide abolished all staining (see Supplemental Figs. 1 and 2).
Statistics. All data were tested for significance using Student's t-test and ANOVA followed by Bonferroni's multiple-comparison test. Only data with P < 0.05 were considered statistically significant. Data are reported as means ± SE.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous experiments have provided evidence for the regulation of pendrin during NH4Cl loading at the level of protein abundance and subcellular localization (9, 18, 19, 27). These results implied that pendrin is regulated by acid-base status, focusing on its function as a bicarbonate secretory protein. More recently, it was shown that pendrin regulation directly correlates with urinary Cl– absorption, suggesting that pendrin is an important determinant for Cl– conservation and thus blood pressure regulation (19, 30). However, these findings raised the question of whether pendrin is only regulated by urinary Cl– excretion and load or if metabolic acidosis is a second determinant of pendrin abundance.
Our data demonstrate that 1) pendrin expression is reduced during Cl– loading with NH4Cl or NaCl, as previously demonstrated (9, 18, 27, 30); 2) pendrin expression is increased when urinary Cl– excretion is reduced, as in the case of Na2SO4 loading, similar to what has been demonstrated for furosemide treatment and NaCl restriction (19, 30); 3) severe metabolic acidosis with low urinary Cl– excretion, as induced by (NH4)2SO4 loading, is associated with reduced pendrin expression and the relative abundance of pendrin-expressing cells; 4) mild metabolic acidosis with low urinary Cl– excretion, as induced by acetazolamide treatment, prevents the expected stimulation of pendrin expression and even reduced the relative abundance of pendrin-expressing cells; 5) increased urinary acidification and stimulated net anion excretion does not influence pendrin expression, as evident from high-protein diet experiments; and 6) the systemic acid-base status but not urinary pH or acid excretion are associated with the downregulation of pendrin abundance, as demonstrated by the fact that (NH4)2SO4 caused an acidic urinary pH, whereas acetazolamide, alkaline urine, and both prevented the expected increase in pendrin expression. The reduction in pendrin expression during (NH4)2SO4 loading may be most likely caused by the more severe metabolic acidosis compared with the acetazolamide treatment. Interestingly, these results and previous reports have suggested that pendrin abundance in the kidney may be regulated either on the cellular level (as seen in cases where Cl– was primarily manipulated) (19, 24) or on the level of the whole collecting duct system altering the number of pendrin-expressing cells (as in cases where primarily acid-base status was altered). The underlying mechanisms of this potentially differential regulation should be addressed in future studies.
Distal Cl– delivery has been suggested to be a major regulator of pendrin expression (24). In our set of data, no clear correlation between total Cl– excretion, fractional excretion of Cl–, and pendrin expression could be established if the acid-base status was not taken into consideration. However, the actual distal Cl– delivery rates are difficult to estimate in our mouse models since we did not investigate other transport proteins affecting transcellular or paracellular Cl– transport, such as Na+/Cl– cotransport, epithelial Na+ channels, claudin 2, WNK kinases, or ClC-k channels.
Aldosterone, angiotensin II, and vasopressin have been implicated in the regulation of pendrin expression and activity (2, 17, 25). Verlander et al. (25, 26) and Wall et al. (30) have suggested that NaCl restriction and aldosterone increase pendrin expression and translocation into the luminal membrane. In contrast, Adler et al. (1) recently demonstrated that aldosterone decreased endogenous pendrin mRNA abundance in HEK-293 cells. Moreover, aldosterone reduced the pendrin promotor-driven luciferase activity in HEK-293 cells (1). Thus, the role of aldosterone in pendrin regulation in the kidney remains controversial. Even though we did not measure aldosterone levels in our experiments, we hypothesize that aldosterone is not a major regulator of pendrin expression since we imposed various conditions where aldosterone levels were either increased (NH4Cl and acetazolamide) or decreased (NaCl loading) but pendrin abundance was found to be decreased in all conditions. The vasopressin analog desmopressin increased in Brattleboro rat pendrin mRNA, an effect possibly mediated by V2 receptors (2). We did not measure vasopressin levels in our mouse models, but serum osmolarity was increased in two groups, (NH4)2SO4 and acetazolamide, and associated with lower pendrin expression levels. Thus, vasopressin may be an additional and independent regulator of pendrin expression.
Our data are consistent with the recent report from Adler et al. (1), where a pH-dependent regulation of pendrin promoter activity in HEK293 cells was demonstrated. There, extracellular acidification reduced and alkalinization increased promoter activity (1).
Taken together, the data suggest that pendrin expression is primarily correlated to urinary Cl– excretion and may function there in the regulation of transcellular Cl– absorption. However, pendrin abundance may also be regulated by systemic acid-base status despite low urinary Cl– excretion. Metabolic acidosis associated with low urinary Cl– excretion downregulates pendrin expression or at least prevents its stimulation. The sensing mechanism for metabolic acidosis must be located either intracellularly or at the basolateral side of the cells as only metabolic acidosis but not urinary acidification per se influence pendrin expression, as evident from the (NH4)2SO4, acetazolamide, and protein diet experiments. Alternatively, the signal(s) for pendrin expression could be generated in other cells or organs but must involve sensing of urinary Cl– excretion and the systemic acid-base status.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
* P. Hafner and R. Grimaldi contributed equally to this work. ![]()
1 Supplemental material for this article is available online at the American Journal of Physiology-Cell Physiology website. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Amlal H, Sheriff S, Faroqui S, Ma L, Barone S, Petrovic S, Soleimani M. Regulation of acid-base transporters by vasopressin in the kidney collecting duct of Brattleboro rat. Am J Nephrol 26: 194–205, 2006.[CrossRef][Web of Science][Medline]
3. Bagnis C, Marshansky V, Breton S, Brown D. Remodeling the cellular profile of collecting ducts by chronic carbonic anhydrase inhibition. Am J Physiol Renal Physiol 280: F437–F448, 2001.
4. Brown D, Lydon J, McLaughlin M, Stuart-Tilley A, Tyszkowski R, Alper S. Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochem Cell Biol 105: 261–267, 1996.[CrossRef][Web of Science][Medline]
5. Chan JC. The rapid determination of urinary titratable acid and ammonium and evaluation of freezing as a method of preservation. Clin Biochem 5: 94–98, 1972.[CrossRef][Web of Science][Medline]
6. Eckardt KU, Kurtz A, Bauer C. Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol Renal Fluid Electrolyte Physiol 256: F942–F947, 1989.
7. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411–422, 1997.[CrossRef][Web of Science][Medline]
8. Everett LA, Green ED. A family of mammalian anion transporters and their involvement in human genetic diseases. Hum Mol Genet 8: 1883–1891, 1999.
9. Frische S, Kwon TH, Frokiaer J, Madsen KM, Nielsen S. Regulated expression of pendrin in rat kidney in response to chronic NH4Cl or NaHCO3 loading. Am J Physiol Renal Physiol 284: F584–F593, 2003.
10. Greger R. Chloride transport in thick ascending limb, distal convolution, and collecting duct. Annu Rev Physiol 50: 111–122, 1988.[CrossRef][Web of Science][Medline]
11. Jentsch TJ. Chloride transport in the kidney: lessons from human disease and knockout mice. J Am Soc Nephrol 16: 1549–1561, 2005.
12. Khanna A, Simoni J, Wesson DE. Endothelin-induced increased aldosterone activity mediates augmented distal nephron acidification as a result of dietary protein. J Am Soc Nephrol 16: 1929–1935, 2005.
13. Kim YH, Kwon TH, Frische S, Kim J, Tisher CC, Madsen KM, Nielsen S. Immunocytochemical localization of pendrin in intercalated cell subtypes in rat and mouse kidney. Am J Physiol Renal Physiol 283: F744–F754, 2002.
14. Knauf F, Yang CL, Thomson RB, Mentone SA, Giebisch G, Aronson PS. Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. Proc Natl Acad Sci USA 98: 9425–9430, 2001.
15. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. J Histochem Cytochem 22: 1077–1083, 1974.[Abstract]
16. Mount DB, Romero MF. The SLC26 gene family of multifunctional anion exchangers. Pflügers Arch 447: 710–721, 2004.[CrossRef][Web of Science][Medline]
17. Pech V, Kim YH, Weinstein AM, Everett LA, Pham TD, Wall SM. Angiotensin II increases chloride absorption in the cortical collecting duct in mice through a pendrin-dependent mechanism. Am J Physiol Renal Physiol 292: F914–F920, 2007.
18. Petrovic S, Wang Z, Ma L, Soleimani M. Regulation of the apical Cl–/HCO3– exchanger pendrin in rat cortical collecting duct in metabolic acidosis. Am J Physiol Renal Physiol 284: F103–F112, 2003.
19. Quentin F, Chambrey R, Trinh-Trang-Tan MM, Fysekidis M, Cambillau M, Paillard M, Aronson PS, Eladari D. The Cl–/HCO3– exchanger pendrin in the rat kidney is regulated in response to chronic alterations in chloride balance. Am J Physiol Renal Physiol 287: F1179–F1188, 2004.
20. Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA, Green ED. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 98: 4221–4226, 2001.
21. Soleimani M, Greeley T, Petrovic S, Wang Z, Amlal H, Kopp P, Burnham CE. Pendrin: an apical Cl–/OH–/HCO3– exchanger in the kidney cortex. Am J Physiol Renal Physiol 280: F356–F364, 2001.
22. Stehberger P, Schulz N, Finberg KE, Karet FE, Giebisch G, Lifton RP, Geibel JP, Wagner CA. Localization and regulation of the ATP6V0A4 (a4) vacuolar H+-ATPase subunit defective in an inherited form of distal renal tubular acidosis. J Am Soc Nephrol 14: 3027–3038, 2003.
23. Teng-umnuay P, Verlander JW, Yuan W, Tisher CC, Madsen KM. Identification of distinct subpopulations of intercalated cells in the mouse collecting duct. J Am Soc Nephrol 7: 260–274, 1996.[Abstract]
24. Vallet M, Picard N, Loffing-Cueni D, Fysekidis M, Bloch-Faure M, Deschenes G, Breton S, Meneton P, Loffing J, Aronson PS, Chambrey R, Eladari D. Pendrin regulation in mouse kidney primarily is chloride-dependent. J Am Soc Nephrol 17: 2153–2163, 2006.
25. Verlander JW, Hassell KA, Royaux IE, Glapion DM, Wang ME, Everett LA, Green ED, Wall SM. Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension. Hypertension 42: 356–362, 2003.
26. Verlander JW, Kim YH, Shin W, Pham TD, Hassell KA, Beierwaltes WH, Green ED, Everett L, Matthews SW, Wall SM. Dietary Cl– restriction upregulates pendrin expression within the apical plasma membrane of type B intercalated cells. Am J Physiol Renal Physiol 291: F833–F839, 2006.
27. Wagner CA, Finberg KE, Stehberger PA, Lifton RP, Giebisch GH, Aronson PS, Geibel JP. Regulation of the expression of the Cl–/anion exchanger pendrin in mouse kidney by acid-base status. Kidney Int 62: 2109–2117, 2002.[CrossRef][Web of Science][Medline]
29. Wall SM, Hassell KA, Royaux IE, Green ED, Chang JY, Shipley GL, Verlander JW. Localization of pendrin in mouse kidney. Am J Physiol Renal Physiol 284: F229–F241, 2003.
30. Wall SM, Kim YH, Stanley L, Glapion DM, Everett LA, Green ED, Verlander JW. NaCl restriction upregulates renal Slc26a4 through subcellular redistribution: role in Cl– conservation. Hypertension 44: 982–987, 2004.
31. Wesson DE. Dietary acid increases blood and renal cortical acid content in rats. Am J Physiol Renal Physiol 274: F97–F103, 1998.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |